RxDoctor Payments Data

Eugene Wolf

Orthopaedic Surgery · San Francisco, CANPI 1386683621

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $987,854 of the $988,011 with a category attached, or 100.0%. Arthrex accounts for 100.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $546,291 and has fallen 90.2% since, to $53,415 in 2021. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$988,011in general payments, 2019–2025

Across 11 payments — averaging $89,819 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$988K
  • Stryker$157

What the payments were for

  • Royalty or licence$987,854100%
  • Food & beverage$1570%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex9$987,854
Stryker2$157

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$988,011 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Other orthopaedic surgery in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →